iForum™ 2021 Virtual User Group

The Premier Virtual Differentiated iPSC Meeting - From Ideation to Implementation

Join us for the first virtual iForum™ meeting where innovators from academia, government, biotech, and pharma will detail breakthrough applications enabled by differentiated human iPSCs. Register now for this free, two-day, online event.

Dates

Wednesday, January 27th - Thursday, January 28th

Speakers

The full list of speakers, talk titles and abstracts will be announced soon. The current list of confirmed speakers includes:

• Caroline Archer, PhD - AstraZeneca
• Silvia Cainarca, PhD - AXXAM, S.p.A.
• Yasunari Kanda, PhD - National Institute of Health Sciences, Japan
• Tomohiro Kawamoto, PhD - Axcelead Drug Discovery Partners
• Camille Nicoleau, PhD - IPSEN
• Francesca Pistollato, PhD - European Commission, Joint Research Centre
• Frederick Sannajust, PhD - Independent Safety Pharmacology/Toxicology Consultant, Former Executive Director of Safety and Exploratory Safety Pharmacology at MERCK Research Laboratories, West-Point, PA, USA.
• Ilyas Singeç, MD, PhD - Director, Stem Cell Translation Laboratory, NIH Regenerative Medicine Program, National Center for Advancing Translational Sciences (NCATS)
• Takahiro Tanaka, PhD, RPh - Axcelead Drug Discovery Partners
• Marija Usenovic, PhD - Merck & Co
• Alison Walker, PhD - AstraZeneca
• More to be announced soon!

Research-focused Agenda

iForum 2021 Meeting agenda is packed with thought-provoking and visionary scientific presentations. This 2 half-day event will highlight the use of human iPSC-derived cells for disease modeling, drug discovery and predictive toxicology in the cardiac and neural fields.

Partners